Angiogenesis by endothelial cell transplantation. 2001

E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
Toronto General Hospital, Toronto General Research Institute, University Health Network, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

OBJECTIVE Myocardial angiogenesis may improve regional perfusion and perhaps function after cardiac injury. We evaluated the effect of endothelial cell transplantation into a myocardial scar on angiogenesis and ventricular function, as an alternative to angiogenic gene or protein therapy. RESULTS A transmural myocardial scar was created in the left ventricular free wall of rat hearts by cryoinjury. Allogeneic aortic endothelial cells were injected into the scar 2 weeks after cryoinjury. A cluster of transplanted cells was identified at the site of injection 1 day and 1 week after transplantation, but not after 2 weeks. The size of this cluster of transplanted cells decreased as vascular density in the transplanted scar tissue increased with time. Six weeks after transplantation, vascular density was significantly greater in transplanted hearts than in control hearts. Regional blood flow, by microsphere analysis, was greater in the transplanted rats. Systolic and diastolic ventricular function was similar between groups. In a second series of experiments, syngeneic aortic endothelial cells labeled with bromodeoxyuridine were transplanted 2 weeks after cryoinjury. Vascular density in the transplanted scar was greater than in controls. Labeled transplanted endothelial cells were identified forming part of the newly developed blood vessels. No difference in vascular density was found between allogeneic and syngeneic cell transplantation. Vascular endothelial growth factor was not expressed at greater levels in the transplanted cells or the myocardial scar. CONCLUSIONS Transplanted endothelial cells stimulated angiogenesis, were incorporated into the new vessels, and increased regional perfusion in myocardial scar tissue, but did not improve global function in this cryoinjury rat model.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D009204 Myocardial Revascularization The restoration of blood supply to the myocardium. (From Dorland, 28th ed) Internal Mammary Artery Implantation,Myocardial Revascularizations,Revascularization, Myocardial,Revascularizations, Myocardial
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006335 Heart Injuries General or unspecified injuries to the heart. Cardiac Rupture, Traumatic,Heart Rupture, Traumatic,Injuries, Heart,Cardiac Ruptures, Traumatic,Heart Injury,Heart Ruptures, Traumatic,Injury, Heart,Rupture, Traumatic Cardiac,Rupture, Traumatic Heart,Ruptures, Traumatic Cardiac,Ruptures, Traumatic Heart,Traumatic Cardiac Rupture,Traumatic Cardiac Ruptures,Traumatic Heart Rupture,Traumatic Heart Ruptures
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016228 Endothelial Growth Factors These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences. Endothelial Cell-Derived Growth Factors,alpha-Endothelial Growth Factor,beta-Endothelial Growth Factor,ECDGF,Endo-GF,Endothelial Growth Factor,Endothelial Growth Factor Polypeptides,Endothelial Cell Derived Growth Factors,Growth Factor, Endothelial,Growth Factor, alpha-Endothelial,Growth Factor, beta-Endothelial,Growth Factors, Endothelial,alpha Endothelial Growth Factor,beta Endothelial Growth Factor
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
February 2003, The Journal of thoracic and cardiovascular surgery,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
December 2011, Nihon rinsho. Japanese journal of clinical medicine,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
January 2003, Pacing and clinical electrophysiology : PACE,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
March 1994, Arzneimittel-Forschung,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
April 1998, The international journal of biochemistry & cell biology,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
March 2007, Circulation research,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
March 1996, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
May 2010, Blood,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
March 2010, Regenerative medicine,
E J Kim, and R K Li, and R D Weisel, and D A Mickle, and Z Q Jia, and S Tomita, and T Sakai, and T M Yau
January 1995, Cell transplantation,
Copied contents to your clipboard!